Archive for the ‘biotech/medical’ category: Page 2415
Apr 17, 2017
Hospital makes $119 million bet on virtual, augmented reality center
Posted by Nancie Hunter in categories: augmented reality, biotech/medical
“The 192,000-square-foot facility will house UNMCs Interprofessional Experiential Center for Enduring Learning, or iEXCEL program, which aims to help physicians and other healthcare professionals do clinical training exercises and develop surgical skills via advanced simulation technologies, virtual immersive reality, augmented reality and holographic technologies, officials say.
The center’s advancements will include the creation of 3D/virtual and augmented reality content for clinical and surgical training modules; leading-edge technology such as the iEXCEL Helix – an extended 280-degree curved screen creating a 2-D/3D immersive environment; laser-based “3D iSpace,” a five-sided virtual immersive reality environment, and a 130-seat holographic auditorium.
The goal is to move beyond traditional lecture-based models to embrace more hands-on experiential learning, which can improve retainment of skills competencies proficiencies. Thus, the traditional mentor-based “see one, do one, teach one” training model for physicians will now be complemented by human patient simulators, surgical simulation, interactive visualization tools such as head-mounted displays, interactive “learning walls” and 3D virtual immersive reality environments.”
Continue reading “Hospital makes $119 million bet on virtual, augmented reality center” »
Apr 17, 2017
We Must Prepare for CRISPR Bioterror Threats
Posted by Shane Hinshaw in categories: bioengineering, biotech/medical, genetics, government
- An advisory council has urged the U.S. to establish a new body that creates plans for national biodefense and to set aside a $2 billion standby fund to address emerging bioterror threats.
- As gene editing technology advances, the potential for its use as a weapon increases, and preparing for such threats before they happen is of the utmost importance.
Though the technology promises seemingly innumerable ways to positively impact human life, gene editing is truly a double-edged sword, with nearly as many potentially negative consequences as benefits. Now, an advisory council to President Obama is urging the government to start creating countermeasures for the negative use of emerging biotechnologies.
This month, the President’s Council of Advisors on Science and Technology (PCAST) wrote a letter to President Obama recommending measures to address this potential for harm using new technologies. It advocates funding new research into antibiotic and antiviral drugs to combat resistance and having a $250 million fund for the stockpiling of vaccines.
Apr 17, 2017
Swansea University smart bandage trials ‘within 12 months’
Posted by Shane Hinshaw in categories: biotech/medical, internet
Bandages which can detect how a wound is healing and send messages back to doctors could be trialled within the next 12 months, scientists have said.
The bandages would use real-time 5G technology to monitor what treatment is needed and also keep track of a patient’s activity levels.
The work is being led by Swansea University’s Institute of Life Science.
Continue reading “Swansea University smart bandage trials ‘within 12 months’” »
Apr 17, 2017
Removing Aging Cells With a New Class of Senolytic Drug
Posted by Steve Hill in categories: biotech/medical, life extension
A short summary of the recent senescent cell removal therapy being developed by a team in the Netherlands.
A quick summary of the new FOXO4 senescent cell removal therapy by Dr. Oliver Medvedik from LEAF.
Apr 16, 2017
First Artificial Wombs: Researchers now grow human embryos in a laboratory to study pregnancy
Posted by Klaus Baldauf in category: biotech/medical
We all know how to get pregnant or at least should know, but despite so many tips out there boosting the chances of conceiving, the actual first 2 weeks of pregnancy remain an undetectable mystery to science.
A pregnancy test is usually done via markers detecting hormones in specific substances like urine and blood. At the very beginning, though, these hormone levels are just too low to register a positive test. Without actually looking into the womb, nobody can watch fertilized eggs grow. Yes, we understand the process going on, as the embryo (which is basically a mass of cells called blastocyst) starts dropping its outer layer to implant within the uterine lining.
However, only a couple of weeks ago researchers from Rockefeller University were the first to witness and even raise human embryos in a laboratory for the maximum ethically allowable time of 13 days.
Apr 16, 2017
The Transhumanist Future Has No Pope
Posted by Zoltan Istvan in categories: biotech/medical, ethics, transhumanism
Happy Easter…and a reality check: https://motherboard.vice.com/en_us/article/where-were-going-we-dont-need-popes #transhumanism #reason
Modern values, transhumanist technology, and the embrace of reason are making many Catholic rules and rituals absurd.
Everywhere I look, Pope Francis, the 266th pope of the Catholic Church, seems to be in the news—and he is being positively portrayed as a genuinely progressive leader. Frankly, this baffles me. Few major religions have as backwards a philosophical and moral platform as Catholicism. Therefore, no leader of it could actually be genuinely progressive. Yet, no one seems to pay attention to this—no one seems to be discussing that Catholicism remains highly oppressive.
Apr 15, 2017
Urban Tech Trends in 2017
Posted by Klaus Baldauf in categories: biotech/medical, health
A few weeks ago we unveiled the latest eight companies that are part of our URBAN-X smart cities accelerator in Brooklyn. This is the second time we’ve run this program, which differs a little from SOSV’s other ecosystem accelerators, in that the space isn’t constrained by the deep intricacies of a vertical (manufacturing, biotechnology, etc) as much as by environment and mission. The kind of companies we’re interested in working with through this program are changing the way that humans live in cities: they’re working on topics as various as mobility, urban health and safety, energy, waste, water, city planning, construction, and beyond.
We see hundreds of applicants to our program, and interface with hundreds more through our network, mentors, and co-investors. Here are some of the trends we’ve seen ticking up over the last 12 months or so:
Apr 15, 2017
Self-taught artificial intelligence beats doctors at predicting heart attacks
Posted by Simon Waslander in categories: biotech/medical, health, robotics/AI
Doctors have lots of tools for predicting a patient’s health. But—as even they will tell you—they’re no match for the complexity of the human body. Heart attacks in particular are hard to anticipate. Now, scientists have shown that computers capable of teaching themselves can perform even better than standard medical guidelines, significantly increasing prediction rates. If implemented, the new method could save thousands or even millions of lives a year.
“I can’t stress enough how important it is,” says Elsie Ross, a vascular surgeon at Stanford University in Palo Alto, California, who was not involved with the work, “and how much I really hope that doctors start to embrace the use of artificial intelligence to assist us in care of patients.”
Each year, nearly 20 million people die from the effects of cardiovascular disease, including heart attacks, strokes, blocked arteries, and other circulatory system malfunctions. In an effort to predict these cases, many doctors use guidelines similar to those of the American College of Cardiology/American Heart Association (ACC/AHA). Those are based on eight risk factors—including age, cholesterol level, and blood pressure—that physicians effectively add up.
Continue reading “Self-taught artificial intelligence beats doctors at predicting heart attacks” »
Apr 15, 2017
The FDA Just Struck a Deal That Could Replace Animal Testing With a Tiny Chip
Posted by Nancie Hunter in categories: biotech/medical, computing
“A future without animal testing is getting closer. On Tuesday, the Food and Drug Administration agreed to a research-and-development collaboration with Emulate, a company that makes “organs-on-chips” technology.
The hope is that instead of testing new drugs or supplements on animals, researchers can use Emulate’s chips.
To start, the collaboration between the FDA and Emulate will focus on the company’s Liver-Chips, which are meant to show how an animal’s liver may react to a certain drug.
Continue reading “The FDA Just Struck a Deal That Could Replace Animal Testing With a Tiny Chip” »